Welcome to ProbeChem!Global Supplier of Chemical Probes, Inhibitors & Agonists.
EN | CN

You are here:Home-Chemical Inhibitors & Agonists-GPCR-Lysophospholipid Receptor-Icanbelimod
Icanbelimod

Chemical Structure : Icanbelimod

CAS No.: 1514888-56-2

Icanbelimod (CBP-307, CBP307)

Catalog No.: PC-42341Not For Human Use, Lab Use Only.

Icanbelimod (CBP-307) is a highly potent, next-generation highly potent sphingosine-1-phosphate receptor (S1PR) agonist with EC50 of 3.55 nM (S1PR1), specifically targets S1PR1/4/5.

Packing Price Stock Quantity
5 mg $138 In stock
10 mg $218 In stock
25 mg $358 In stock
50 mg $558 In stock
100 mg Get quote

Bulk size, bulk discount!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

Purity & Documentation Purity: >98% (HPLC) Select Batch:

Biological Activity

Icanbelimod (CBP-307) is a highly potent, next-generation highly potent sphingosine-1-phosphate receptor (S1PR) agonist with EC50 of 3.55 nM (S1PR1), specifically targets S1PR1/4/5.
Icanbelimod (CBP-307) has significantly higher potency for S1PR1 than for S1PR4 and S1PR5, and no activity against S1PR2 and S1PR23.
Icanbelimod (CBP-307) has no notable activity for S1PR3 in Chinese hamster ovary cells expressing human S1PRs.
Icanbelimod (CBP-307) demonstrated large (>50%) reductions in lymphocyte counts and, notably, a short elimination half-life (5.3 hours in rats) when indirectly compared with fingolimod (23.4 hours) in vivo.
Icanbelimod (CBP-307) is currently being evaluated in a global phase 2 clinical study in moderate to severe ulcerative colitis and Crohn's disease.

Physicochemical Properties

M.Wt 409.4533632
Formula C23H24FN3O3
Appearance Solid
CAS No.
Storage
Solide Powder
-20 °C 12 Months; 4°C 6 Months
In Solvent
-80 °C 6 Months; -20°C 6 Months
Shipping
Solubility

DMSO: 6.8 mg/mL (Need ultrasonic and warming)

Chemical Name/SMILES

3-Azetidinecarboxylic acid, 1-[[2-fluoro-4-[5-[4-(2-methylpropyl)phenyl]-1,2,4-oxadiazol-3-yl]phenyl]methyl]-

References

1. Patent WO 2015039587 A1.
2. Leiye Yu, et al. Proc Natl Acad Sci U S A. 2022 Apr 19;119(16):e2117716119.
3. Lickliter J, et al. Front Immunol. 2024 Jun 17;15:1380975.

Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

Contact Us sales@probechem.com

Bulk Inquiry

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • *Additional Information:

Get Quote

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • Additional Information: